FDA Adverse Event Malfunction Summary report: N

ONETOUCHPING GLUCOSEMGMTSYSTEM

MDR report key: 3679273 · Received March 14, 2014

Report

Report Number
2531779-2014-06857
Event Type
Malfunction
Date Received
March 14, 2014
Report Date
February 26, 2014
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K080639
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE INITIAL COMPLAINT IS AGAINST THE BATTERY CAP ALONE AND THE CORRECTED INFORMATION IS K032257.

Additional Manufacturer Narrative · 1

THE DEVICE HAS NOT BEEN RETURNED TO ANIMAS FOR EVALUATION. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Additional Manufacturer Narrative · 1

THE DEVICE HAS BEEN RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON 01/21/2015 AS FOLLOWS: NO DAMAGE WAS FOUND TO THE RETURNED BATTERY CAP OR RETURNED CARTRIDGE CAP. NO DAMAGE WAS FOUND TO THE BATTERY COMPARTMENT OR CARTRIDGE COMPARTMENT. THE RETURNED CAPS WERE ABLE TO BE FULLY TIGHTENED AND WERE EASILY REMOVED WITH NO ISSUES. PRODUCT ANALYSIS WAS UNABLE TO DUPLICATE THE INITIAL COMPLIANT. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE.

Description of Event or Problem · 1

ON (B)(6) 2014, THE REPORTER CONTACTED ANIMAS, ALLEGING A CASING/CONDITION (EXTERNAL COMPONENT ISSUE) ISSUE. THIS COMPLAINT IS AGAINST THE BATTERY CAP ALONE. THE REPORTER STATED THAT THE BATTERY CAP COULD NOT BE REMOVED FROM THE PUMP. NO ADDITIONAL INFORMATION WAS AVAILABLE. THIS COMPLAINT IS BEING REPORTED BECAUSE THE REPORTED ISSUE REMAINED UNRESOLVED. THERE WAS NO INDICATION THAT THE PRODUCT CAUSED OR CONTRIBUTED TO AN ADVERSE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
152866 ONETOUCHPING GLUCOSEMGMTSYSTEM INSULIN INFUSION PUMP LZG ANIMAS CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 72 YR